TissGeneSummary for ECEL1 |
Gene summary |
Basic gene information | Gene symbol | ECEL1 |
Gene name | endothelin converting enzyme-like 1 | |
Synonyms | DA5D|DINE|ECEX|XCE | |
Cytomap | UCSC genome browser: 2q37.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001290787.1, NM_004826.3, | |
Description | X converting enzymedamage induced neuronal endopeptidaseendothelin-converting enzyme-like 1 | |
Modification date | 20141222 | |
dbXrefs | MIM : 605896 | |
HGNC : HGNC | ||
Ensembl : ENSG00000171551 | ||
HPRD : 07066 | ||
Vega : OTTHUMG00000133262 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ECEL1 | |
BioGPS: 9427 | ||
Pathway | NCI Pathway Interaction Database: ECEL1 | |
KEGG: ECEL1 | ||
REACTOME: ECEL1 | ||
Pathway Commons: ECEL1 | ||
Context | iHOP: ECEL1 | |
ligand binding site mutation search in PubMed: ECEL1 | ||
UCL Cancer Institute: ECEL1 | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | OvaryEye | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | OVUVM | |
Reference showing the relevant tissue of ECEL1 | ||
Description by TissGene annotations | Protective TissGene in RFS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for ECEL1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | -3.242111366 | -0.918331366 | -2.32378 | 2.27E-05 | 6.69E-05 |
KIRP | -3.277702991 | -0.464099866 | -2.813603125 | 9.02E-08 | 5.48E-07 |
KIRC | -2.469069311 | -1.040442922 | -1.428626389 | 8.77E-06 | 2.07E-05 |
LUAD | -0.875645987 | -3.604839091 | 2.729193103 | 3.00E-11 | 1.95E-10 |
LUSC | -1.074126582 | -3.105432464 | 2.031305882 | 7.77E-06 | 1.79E-05 |
BLCA | -1.081961051 | -3.120708419 | 2.038747368 | 0.00609 | 0.030712381 |
STAD | -0.422362366 | -2.128868616 | 1.70650625 | 0.00168 | 0.008004915 |
LIHC | -1.438437366 | -3.884485366 | 2.446048 | 0.000289 | 0.000890248 |
Top |
TissGene-miRNA for ECEL1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for ECEL1 |
TissGeneSNV for ECEL1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.A455T | COAD | 2 |
p.A378V | STAD | 1 |
p.M294I | SKCM | 1 |
p.A569V | MESO | 1 |
p.A224V | ESCA | 1 |
p.V335I | LGG | 1 |
p.A445T | LUAD | 1 |
p.L270M | HNSC | 1 |
p.Q624L | LIHC | 1 |
p.D594V | BRCA | 1 |
p.A425V | THCA | 1 |
p.R355G | LUAD | 1 |
p.R404C | STAD | 1 |
p.Y687N | LUAD | 1 |
p.S410N | SKCM | 1 |
p.R418H | COAD | 1 |
p.R663W | UCS | 1 |
p.R439Q | SKCM | 1 |
p.R191C | COAD | 1 |
p.D212N | SKCM | 1 |
p.A420V | STAD | 1 |
p.S414Y | LUSC | 1 |
p.G617C | LUAD | 1 |
p.R195Q | STAD | 1 |
p.T608I | UCEC | 1 |
p.Q177R | LIHC | 1 |
p.D142E | COAD | 1 |
p.R756W | KIRP | 1 |
p.E527Q | BRCA | 1 |
p.A569V | LUAD | 1 |
p.A166E | LUAD | 1 |
p.L270Q | HNSC | 1 |
p.S283N | SKCM | 1 |
p.A569V | UCEC | 1 |
p.Q318E | KIRC | 1 |
p.D520N | STAD | 1 |
p.C760F | SKCM | 1 |
p.I721V | LIHC | 1 |
p.K552T | ESCA | 1 |
p.V238M | UCEC | 1 |
p.Q384H | LUAD | 1 |
p.R137C | STAD | 1 |
p.R296Q | LUSC | 1 |
p.R723P | LUAD | 1 |
p.R296Q | HNSC | 1 |
p.E373* | LGG | 1 |
p.S600F | SKCM | 1 |
p.A445D | ESCA | 1 |
p.P739T | LUAD | 1 |
p.A585V | ACC | 1 |
p.G629V | STAD | 1 |
p.R652H | COAD | 1 |
p.V342L | LUAD | 1 |
p.E192K | SKCM | 1 |
p.A305T | ESCA | 1 |
p.A493T | COAD | 1 |
p.H461P | SKCM | 1 |
p.G511D | KICH | 1 |
p.R390H | ESCA | 1 |
p.T636M | STAD | 1 |
p.Y625H | PAAD | 1 |
p.R418H | THYM | 1 |
p.D282N | SKCM | 1 |
p.G604R | LIHC | 1 |
p.E429D | HNSC | 1 |
p.T392A | PAAD | 1 |
p.K552R | ESCA | 1 |
p.T149I | SKCM | 1 |
p.P566L | GBM | 1 |
p.A521D | UCEC | 1 |
p.G623S | SKCM | 1 |
p.L270K | HNSC | 1 |
p.G133S | STAD | 1 |
p.V292L | LUAD | 1 |
p.T343M | BRCA | 1 |
p.C649R | HNSC | 1 |
p.R663W | GBM | 1 |
p.Q444P | LGG | 1 |
p.D330N | SKCM | 1 |
p.A452V | CESC | 1 |
p.R296Q | SKCM | 1 |
p.P584S | SKCM | 1 |
p.D619N | PAAD | 1 |
Top |
TissGeneCNV for ECEL1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for ECEL1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for ECEL1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for ECEL1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for ECEL1 |
TissGeneDrug for ECEL1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for ECEL1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0265213 | Distal arthrogryposis syndrome | 5 | BeFree |
umls:C3554415 | ARTHROGRYPOSIS, DISTAL, TYPE 5D | 4 | CLINVAR,ORPHANET,UNIPROT |
umls:C0005745 | Blepharoptosis | 3 | BeFree |
umls:C0033377 | Ptosis | 3 | BeFree |
umls:C0003886 | Arthrogryposis | 2 | BeFree |
umls:C0027819 | Neuroblastoma | 2 | BeFree |
umls:C0038379 | Strabismus | 2 | BeFree |
umls:C0332878 | Congenital joint contractures | 2 | BeFree |
umls:C0700095 | Central neuroblastoma | 2 | BeFree |
umls:C0009917 | Contracture | 1 | BeFree |
umls:C0013261 | Duane Retraction Syndrome | 1 | BeFree |
umls:C0027868 | Neuromuscular Diseases | 1 | BeFree |
umls:C0029089 | Ophthalmoplegia | 1 | BeFree |
umls:C0158113 | Contracture of joint of hand | 1 | BeFree |
umls:C0175709 | Centronuclear myopathy | 1 | BeFree |
umls:C0221369 | Acquired Camptodactyly | 1 | BeFree |
umls:C0234362 | Synkinesis | 1 | BeFree |
umls:C0426070 | Flexed fetal attitude | 1 | BeFree |
umls:C0685409 | Congenital Camptodactyly | 1 | BeFree |
umls:C0752282 | Congenital Structural Myopathy | 1 | BeFree |